# Photodynamic Therapy (PDT) With Temoporfin for Non-Resectable Non-Small-Cell Lung Cancer

> **NCT01637376** · PHASE1 · WITHDRAWN · sponsor: **University of Arkansas**

## Conditions studied

- Carcinoma, Non-Small-Cell-Lung

## Interventions

- **DRUG:** Temoporfin

## Key facts

- **NCT ID:** NCT01637376
- **Lead sponsor:** University of Arkansas
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2012-07
- **Primary completion:** 2014-01
- **Final completion:** 2014-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No participants were enrolled
- **Last updated:** 2014-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01637376

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01637376, "Photodynamic Therapy (PDT) With Temoporfin for Non-Resectable Non-Small-Cell Lung Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01637376. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*